Spain takes new look at neurology R&D (research and development):
This article was originally published in Clinica
Executive Summary
Spain has pledged renewed commitment to tackling Alzheimer's and Parkinson's, after a "great increase" in the incidence of neurological diseases in recent years. These diseases currently affect 400,000 and 120,000 people, respectively. So said health minister Ana Pastor recently, during comments to parliament on the progress of the new national centre/network for research into neurological diseases (CIEN). The network, which already comprises more than 200 research groups, has a first-year budget of E4m ($4.6m).
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.